| | 
Part, Chapter, Paragraph
1 I, 2. 10. 4| pharmaceutical products, medical devices, patients, caregivers, assets,
2 I, 2. 10. 4| events involving medical devices. In Spain, an Adverse Event
3 II, 5. 3. 7| of anticancer drugs and devices is an important matter of
4 II, 5. 6. 3| years due to the costs of devices, adaptations and arthroplasty
5 II, 5. 8. 6| and stand-alone electronic devices capable of supporting older
6 II, 9 | deficit, use of assistive devices, visual deficit, arthritis,
7 II, 9. 4. 4| deficit, use of assistive devices, visual deficit, arthritis,
8 III, 10. 2. 1| by objective measurement devices such as pedometers (step
9 IV, 11. 6. 4| explicitly regulate medical devices, and all but Germany (implicit)
10 IV, 12. 1 | Pharmaceuticals~and Medical~Devices~ ~ ~Food industry~ ~Several
11 IV, 12. 4 | Pharmaceuticals; Medical Devices; Biotechnology; Safety of
12 IV, 12. 10 | Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel
13 IV, 12. 10 | risk monitoring of medical devices.~The Drug Commission of
14 IV, 12. 10 | Pharmaceuticals and medical devices produced using genetic engineering
15 IV, 12. 10 | Institute for Drugs and Medical Devices/Bundesinstituts für Arzneimittel
16 IV, 13. 7 | medicinal products, medical devices, diagnostic tools and making
17 IV, 13. 7 | constituent parts of medical devices. Their collection and distribution
|
|
| |
